Abstract Background Line probe assays (LPAs) are PCR-based assays used for the rapid
diagnosis of Mycobacterium tuberculosis (MTB) and drug-resistant tuberculosis (DR-TB). But …

Abstract Introduction In 2008, the World Health Organization (WHO) approved a rapid
molecular test known as Line Probe Assay (LiPA) for the diagnosis of multidrug-resistant …

Owing to the burden of multidrug-resistant tuberculosis, molecular techniques have been
approved by the WHO for the rapid diagnosis of the same. The objectives of this prospective …

BACKGROUND: There are limited data on use of line probe assay (LPA) for detection of TB
and Rifampicin resistance among extra-pulmonary tuberculosis (EPTB) patients under …

Tuberculosis (TB) is one of the top 10 causes of death, worldwide. 1 Worldwide 10 million
people developed TB in 2017,(ie, 133 cases per 100,000). 1–3 However, only 6.4 million …

Background: Despite endorsement of the line probe assay (LPA) for the diagnosis of drug-
resistant pulmonary tuberculosis patients, there is limited data available on the performance …

Background Rapid tuberculosis (TB) drug susceptibility testing (DST) is crucial. Genotype
MTBDR sl is a widely deployed World Health Organization (WHO)–endorsed assay …

Only 25% of multidrug-resistant tuberculosis (MDR-TB) cases are currently diagnosed. Line
probe assays (LPAs) enable rapid drug-susceptibility testing for rifampicin (RIF) and …

New diagnostic methods have provided a promising solution for rapid and reliable detection
of drug-resistant TB strains. The aim of this study was to evaluate the performance of the …

The Loopamp™ MTBC kit (TB‐LAMP) is recommended by WHO for Mycobacterium
tuberculosis complex detection in low‐income countries with a still low drug‐resistant …